首页> 外文期刊>Allergy >Asthma control assessment in a pediatric population: Comparison between GINA/NAEPP guidelines, Childhood Asthma Control Test (C-ACT), and physician's rating
【24h】

Asthma control assessment in a pediatric population: Comparison between GINA/NAEPP guidelines, Childhood Asthma Control Test (C-ACT), and physician's rating

机译:儿科人群的哮喘控制评估:GINA / NAEPP指南,儿童哮喘控制测试(C-ACT)和医生评分之间的比较

获取原文
获取原文并翻译 | 示例
           

摘要

Background Guidelines recommend regular assessment of asthma control. The Childhood Asthma Control Test (C-ACT) is a clinically validated tool. Aim To evaluate asthma control according to GINA2006, NAEPP, pediatrician's assessment (PA), and C-ACT in asthmatic children visiting their ambulatory pediatrician or tertiary care pediatric pulmonologist. Methods Demographic data, treatment, and number of severe exacerbations during the previous year were collected. Control was assessed using (i) strict GINA 2006 criteria, (ii) GINA without taking into account the exacerbation item, (iii) NAEPP criteria, and (iv) PA. Children and parents filled out the C-ACT. Results Five hundred and twenty-five children completed the survey (mean age: 7.7 years; 28% ≤ 6 years). 78% had a controller treatment. 58% reported ≥ 1 severe exacerbation. C-ACT was ≤ 19 in 29.5%. Control was not achieved in 76.5%, 55%, 40%, and 34% according to GINA 2006 guidelines, NAEPP guidelines, GINA 2006 without exacerbation criteria, and PA, respectively. C-ACT was significantly lower in children ≤ 6 years old (P = 0.002) or with severe exacerbations (P < 0.0001). According to PA, 89% of patients with a C-ACT > 21 were controlled and 85% of patients with a C-ACT < 17 not controlled. Conclusion We observed discrepancies between the different tools applied to assess asthma control in children, and the impact of age and exacerbations. Cutoff point of 19 of C-ACT was not associated with the best performance compared to PA. Assessment of control should take into account symptoms and lung function as suggested by the latest GINA guidelines as well as exacerbation over a long period.
机译:背景指南建议定期评估哮喘控制。儿童哮喘控制测试(C-ACT)是经过临床验证的工具。目的根据GINA2006,NAEPP,儿科医生评估(PA)和C-ACT对访问其门诊儿科医生或三级护理儿科肺科医生的哮喘儿童进行哮喘控制评估。方法收集前一年的人口统计学资料,治疗方法和严重加重次数。使用(i)严格的GINA 2006标准,(ii)不考虑加重项目的GINA,(iii)NAEPP标准和(iv)PA评估对照。孩子和父母填写了C-ACT。结果525名儿童完成了调查(平均年龄:7.7岁; 28%≤6岁)。 78%接受了控制治疗。 58%的患者报告严重加重≥1。 C-ACT≤19占29.5%。根据GINA 2006指南,NAEPP指南,没有加重标准的GINA 2006和PA分别未达到控制的76.5%,55%,40%和34%。 ≤6岁的儿童(P = 0.002)或严重加重的儿童(P <0.0001)的C-ACT显着降低。根据PA的说法,C-ACT> 21的患者中有89%得到控制,而C-ACT <17的患者中没有85%被控制。结论我们观察到用于评估儿童哮喘控制的不同工具与年龄和病情加重的影响之间存在差异。与PA相比,C-ACT的19分界点与最佳性能无关。控制评估应考虑最新的GINA指南建议的症状和肺功能,以及长期加重病情。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号